Implementation and evaluation of Missouri's Medication First treatment approach for opioid use disorder in publicly-funded substance use treatment programs

被引:31
|
作者
Winograd, Rachel P. [1 ]
Wood, Claire A. [1 ]
Stringfellow, Erin J. [1 ]
Presnall, Ned [2 ]
Duello, Alex [1 ]
Horn, Phil [1 ]
Rudder, Tim [3 ]
机构
[1] Univ Missouri St Louis, Missouri Inst Mental Hlth, 4633 World Pkwy Circle Dr, St Louis, MO 63134 USA
[2] Washington Univ, Dept Psychiat, 1 Brookings Dr, St Louis, MO 63130 USA
[3] Missouri Dept Mental Hlth, 1706 East Elm St, Jefferson City, MO 65101 USA
关键词
Opioid use disorder; Buprenorphine; Substance use treatment; State targeted response; LONG-TERM OUTCOMES; ASSISTED TREATMENT; BUPRENORPHINE TREATMENT; MAINTENANCE THERAPY; COUNSELOR ATTITUDES; UNITED-STATES; CARE; DEPENDENCE; BARRIERS; DISCONTINUATION;
D O I
10.1016/j.jsat.2019.06.015
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background: Leaders of Missouri's State Targeted Response to the opioid crisis (STR) grant have prioritized increasing access to treatment medications for opioid use disorder (MOUD) through a "Medication First" approach. This conceptual framework prioritizes rapid, sustained, low-barrier access to MOUD for optimal impact on decreased illicit drug use and mortality. Medication First principles and practices were facilitated through state-level structural changes and disseminated to participating community treatment programs via a multi-pronged, multi-disciplinary approach. In the first nine months of STR, 14 state-contracted treatment agencies operating 38 sites used STR funding to implement the Medication First model. Methods: We utilized state billing and service data to make comparisons before and during STR on the following outcomes: MOUD utilization, timely access to MOUD, amount of psychosocial services delivered, treatment retention at 1, 3, and 6 months, and monthly price of treatment. We conducted follow-up analyses examining differences across MOUD types (no medication, methadone, buprenorphine, oral naltrexone, mixed antagonist + agonist, and extended release naltrexone). Results: During STR, MOUD utilization increased (44.8% to 85.3%), timeliness of MOUD receipt improved (Median of 8 days vs. 0 days), there were fewer psychosocial services delivered, treatment retention improved at one, three, and six month timeframes, and the median cost per month was 21% lower than in the year prior to STR. All differences were driven by increased utilization of buprenorphine. Conclusions: Findings suggest Medication First implementation through STR was successful in all targeted domains. Though much more work is needed to further reduce logistical, financial, and cultural barriers to improved access to maintenance MOUD, the steps taken through Missouri's STR grant show significant promise at making swift and drastic transformations to a system of care in response to a growing public health emergency.
引用
收藏
页码:55 / 64
页数:10
相关论文
共 50 条
  • [21] CAUTIONARY TALES FOR MEDICATION TREATMENT IN OPIOID USE DISORDER
    Loftus, Mirela
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2024, 63 (10): : S71 - S71
  • [22] Treatment Approaches for Opioid Use Disorder Offered in US Substance Use Treatment Facilities
    Park, Tae Woo
    Shuey, Bryant
    Liebschutz, Jane
    Cantor, Jonathan
    Anderson, Timothy S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 332 (06): : 502 - 504
  • [23] An Approach to Enhancing Medication Treatment for Opioid Use Disorder in the HEALing Communities Study
    Wai, Jonathan M.
    Blevins, Derek
    Hunt, Tim
    Gilbert, Louisa
    Campbell, Aimee N. C.
    Levin, Frances R.
    El-Bassel, Nabila
    Nunes, Edward
    PSYCHIATRIC SERVICES, 2024, 75 (06) : 580 - 588
  • [24] Treating Adolescents With Opioid Use Disorder: A Medication-Assisted Treatment Approach
    Russ, Brian R. R.
    Gorham, Jessica D.
    FAMILY JOURNAL, 2024, 32 (02): : 215 - 221
  • [25] Obstacles to treatment retention in opioid use disorder: An international substance use disorder treatment worker survey
    Jones, Matthew
    Guirguis, Amira
    Watkins, Alan
    Bradshaw, Ceri
    Mohamed, Lily
    Schifano, Fabrizio
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2023, 38 (05)
  • [26] Implementation of medication-assisted treatment for opioid use disorder in the veterans health administration
    Midboe, Amanda
    Becker, William
    Drexler, Karen
    Hawkins, Eric
    McGovern, Mark
    IMPLEMENTATION SCIENCE, 2019, 14
  • [27] INVESTIGATING THE EFFECTS OF SAN FRANCISCO'S TREATMENT ON DEMAND INITIATIVE ON A PUBLICLY-FUNDED SUBSTANCE ABUSE TREATMENT SYSTEM: A TIME SERIES ANALYSIS
    Sears, Clare
    Davis, Thomas
    Guydish, Joseph
    Gleghorn, Alice
    JOURNAL OF PSYCHOACTIVE DRUGS, 2009, 41 (03) : 297 - 304
  • [28] Evaluation of a Program Designed to Support Implementation of Prescribing Medication for Treatment of Opioid Use Disorder in Primary Care Practices
    Hall, Tristen L.
    Mendez, David
    Sobczak, Chelsea
    Mathieu, Susan
    Wiggins, Kimberly
    Cebuhar, Kathy
    Quintana, Lauren
    Weiss, Jacob
    Knierim, Kyle
    ANNALS OF FAMILY MEDICINE, 2025, 23 (01) : 44 - 51
  • [29] Prevalence of and Factors Related to Tobacco Ban Implementation in Substance Use Disorder Treatment Programs
    Jessica L. Muilenburg
    Tanja C. Laschober
    Lillian T. Eby
    Nancy D. Moore
    Administration and Policy in Mental Health and Mental Health Services Research, 2016, 43 : 241 - 249
  • [30] Prevalence of and Factors Related to Tobacco Ban Implementation in Substance Use Disorder Treatment Programs
    Muilenburg, Jessica L.
    Laschober, Tanja C.
    Eby, Lillian T.
    Moore, Nancy D.
    ADMINISTRATION AND POLICY IN MENTAL HEALTH AND MENTAL HEALTH SERVICES RESEARCH, 2016, 43 (02) : 241 - 249